Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dolutegravir”

262 trials

Showing 20 of 262 results

Early research (Phase 1)Study completedNCT02185300
What this trial is testing

Bioavailability Study of a Dolutegravir Dispersible Tablet and Effect of Different Types of Water on the Dispersible Tablet in Healthy Volunteers

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 15
Not applicableWithdrawnNCT03964584
What this trial is testing

Evaluation of the Neurological and Psychiatric Adverse Events of Dolutegravir and Bictegravir in Real Life

Who this might be right for
HIV+ Patients
Fondation Ophtalmologique Adolphe de Rothschild
Large-scale testing (Phase 3)Study completedNCT02486133
What this trial is testing

Dual Therapy With Boosted Darunavir + Dolutegravir

Who this might be right for
HIV-Infection
Technical University of Munich 269
Early research (Phase 1)Study completedNCT00774735
What this trial is testing

GSK1349572 Drug Interaction Study With Protease Inhibitors

Who this might be right for
Healthy SubjectsInfection, Human Immunodeficiency Virus
GlaxoSmithKline 30
Large-scale testing (Phase 3)UnknownNCT04979468
What this trial is testing

Early DOlutegravir/LAmivudine Switching After Virological Suppression (EDOLAS Study)

Who this might be right for
HIV-1-infection
Societa' Italiana Di Malattie Infettive E Tropicali 440
Large-scale testing (Phase 3)Study completedNCT01227824
What this trial is testing

A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily

Who this might be right for
Infection, Human Immunodeficiency Virus I
ViiV Healthcare 828
Large-scale testing (Phase 3)UnknownNCT04155554
What this trial is testing

Neurological Monitoring in Patients Switching From Dolutegravir Based Regimen to Bictegravir Based Regimen

Who this might be right for
HIV-1-infection
Azienda Ospedaliera Universitaria Senese 100
Testing effectiveness (Phase 2)Ended earlyNCT02386098
What this trial is testing

Strategy-confirming Study of BMS-955176 to Treat HIV-1 Infected Treatment-experienced Adults

Who this might be right for
HIV Infections
ViiV Healthcare 86
Early research (Phase 1)Study completedNCT05489406
What this trial is testing

Relative Bioavailability Study to Investigate a Potential Interaction Between DTG DT and F/TAF TOS.

Who this might be right for
Hiv
Radboud University Medical Center 16
Post-approval studies (Phase 4)Study completedNCT03033836
What this trial is testing

Dolutegravir Plus Tenofovir/Lamivudine or Emtricitabine in HIV-1 Infected Transgender Women

Who this might be right for
HIV Infections
Fundación Huésped 60
Large-scale testing (Phase 3)Study completedNCT01231516
What this trial is testing

GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 724
Testing effectiveness (Phase 2)Study completedNCT05630872
What this trial is testing

Pharmacokinetics and Safety of Double-dose Dolutegravir When Used With Rifapentine for HIV-associated Tuberculosis

Who this might be right for
HIV-associated Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 30
Early research (Phase 1)Study completedNCT01332565
What this trial is testing

Investigate the Pharmacokinetics, Safety and Tolerability of GSK1349572 (Dolutegravir, DTG) in Healthy Japanese Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 10
Post-approval studies (Phase 4)Study completedNCT04880395
What this trial is testing

Dolutegravir-Lamivudine for naïve HIV-Infected Patients With ≤200 CD4/mm3

Who this might be right for
HIV-1-infection
Fundación Huésped 265
Testing effectiveness (Phase 2)Active Not RecruitingNCT05993767
What this trial is testing

UNIVERSAL 1: Pharmacokinetic Study of a Novel DTG/FTC/TAF Dose Ratio for Children

Who this might be right for
HIV Infection
PENTA Foundation 50
Not applicableLooking for participantsNCT06762054
What this trial is testing

Investigating the Optimal Management of Dolutegravir Resistance

Who this might be right for
HIV-1-infection
University of Nairobi 6,600
Not applicableUnknownNCT04311944
What this trial is testing

Early Fast-Track Versus Standard Care for Persons With HIV Initiating TLD

Who this might be right for
HIV-1-infection
Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic 242
Not applicableStudy completedNCT04238767
What this trial is testing

Dolutegravir in Real Life in Lesotho

Who this might be right for
HIV-1-infection
Swiss Tropical & Public Health Institute 1,433
Post-approval studies (Phase 4)Study completedNCT04229290
What this trial is testing

Second-line Switch to Dolutegravir Study

Who this might be right for
HIV-1-infection
University of Nairobi 795
Not applicableNot Yet RecruitingNCT06637813
What this trial is testing

Establishment of a Database of HIV Subjects Initiating or Simplifying Dual Therapy With Dolutegravir/Lamivudine

Who this might be right for
HIV -1 Infection
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 1,220
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation